RecruitingNCT06120387

Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer


Sponsor

Xuesong Li

Enrollment

90 participants

Start Date

Nov 10, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In this study, we propose to conduct an ambispective study to analyze the safety of preserved renal unit surgery combined with postoperative adjuvant radiotherapy in patients with limited stage ureteral cancer with high risk factors, and the efficacy analysis compared with traditional radical surgery. It is hoped that a treatment method that preserves patients' renal function to improve the tolerance of subsequent drug therapy without decreasing the effect of tumor treatment can be achieved in patients with high-risk factors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates whether adding radiation therapy after surgery can improve outcomes for patients with high-risk ureteral cancer (cancer of the tube connecting the kidney to the bladder) who had kidney-sparing surgery rather than full removal of the kidney. **You may be eligible if...** - You are 18 years old or older - You have high-risk ureteral cancer (grade 3, multiple tumors, or T2–T4 stage) - You had surgery (either partial removal of the ureter or full removal of the kidney and ureter) - You do not have cancer spread to distant organs or lymph nodes - You have not had pelvic radiation before **You may NOT be eligible if...** - Your cancer has already spread to distant organs or lymph nodes at the time of surgery - Your surgery could not remove all visible cancer (R2 resection) - You have a history of bladder cancer, inflammatory bowel disease, or prior abdominal radiation - You are pregnant or breastfeeding - You have significant heart disease or a bleeding disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERadical surgery

Radical nephroureterectomy

RADIATIONKidney sparing surgery+Postoperative radiotheray

Kidney sparing surgery+Postoperative radiotheray


Locations(2)

Departmeng of Urology, Peking University First Hospital

Beijing, China

Department of Radiotherapy Oncology, Peking University First Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06120387


Related Trials